Current Obesity Reports最新文献_第9页

Effects of Calorie Restriction on Preserving Male Fertility Particularly in a State of Obesity. 限制热量对保持男性生育能力的影响，尤其是在肥胖状态下。

IF 9.5 2区医学

Current Obesity Reports Pub Date : 2024-06-01 Epub Date: 2024-03-15 DOI: 10.1007/s13679-024-00557-0

Mohammad Ishraq Zafar, Xiao Chen

{"title":"Effects of Calorie Restriction on Preserving Male Fertility Particularly in a State of Obesity.","authors":"Mohammad Ishraq Zafar, Xiao Chen","doi":"10.1007/s13679-024-00557-0","DOIUrl":"10.1007/s13679-024-00557-0","url":null,"abstract":"<p><strong>Purpose of review: </strong>Highlight the importance of exploring nutritional interventions that could be applied as alternative or supplementary therapeutic strategies to enhance men's fertility.</p><p><strong>Recent findings: </strong>Lifestyle choices have prompted extensive discussions regarding its implications and applications as a complementary therapy. The growing concern over the decline in sperm quality underscores the urgency of investigating these alternative interventions. Calorie restriction (CR) has emerged as a promising strategy to improve male fertility. The efficacy of CR depends on factors like age, ethnicity and genetics. Clinical studies, such as CALERIE, have shown an improvement in serum testosterone level and sexual drive in men with or without obesity. Additionally, CR has been shown to positively impact sperm count and motility; however, its effects on sperm morphology and DNA fragmentation remain less clear, and the literature has shown discrepancies, mainly due to the nature of technically dependent assessment tools. The review advocates a personalized approach to CR, considering individual health profiles to maximize its benefits. It underscores the need for routine, accessible diagnostic techniques in male reproductive health. It suggests that future research should focus on personalized dietary interventions to improve male fertility and overall well-being in individuals with or without obesity and unravel CR's immediate and lasting effects on semen parameters in men without obesity.</p>","PeriodicalId":10846,"journal":{"name":"Current Obesity Reports","volume":" ","pages":"256-274"},"PeriodicalIF":9.5,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140136598","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Adjuvant and Neo-Adjuvant Anti-Obesity Medications and Bariatric Surgery: A Scoping Review. 辅助和新辅助抗肥胖药物与减肥手术：范围综述。

IF 9.5 2区医学

Current Obesity Reports Pub Date : 2024-06-01 Epub Date: 2024-03-20 DOI: 10.1007/s13679-024-00558-z

Theo Sher, Michelle McGee, Christopher DuCoin, Joseph Sujka, Salvatore Docimo

{"title":"Adjuvant and Neo-Adjuvant Anti-Obesity Medications and Bariatric Surgery: A Scoping Review.","authors":"Theo Sher, Michelle McGee, Christopher DuCoin, Joseph Sujka, Salvatore Docimo","doi":"10.1007/s13679-024-00558-z","DOIUrl":"10.1007/s13679-024-00558-z","url":null,"abstract":"<p><strong>Purpose of review: </strong>To comprehensively summarize the current body of literature on the topic of adjuvant and neoadjuvant pharmacotherapy used in combination with bariatric surgery.</p><p><strong>Recent findings: </strong>Anti-obesity medications (AOMs) have been used since the mid-1900s; however, their use in combination with bariatric surgery is a newer area of research that is rapidly growing. Pharmacotherapy may be used before (neoadjuvant) or after (adjuvant) bariatric surgery. Recent literature suggests that adjuvant AOMs may address weight regain and inadequate weight loss following bariatric surgery. Research on neoadjuvant AOM used to optimize weight loss before bariatric surgery is more limited. A literature review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Thirty-four studies were included after screening and exclusion of irrelevant records. Included studies were as follows: seven prospective studies on adjuvant AOM use, 23 retrospective studies on adjuvant AOM use, one prospective study on adjuvant and neoadjuvant AOM use, one retrospective study on adjuvant or neoadjuvant AOM use, one prospective study on neoadjuvant AOM use, and one case series on neoadjuvant AOM use. In the following scoping review, each of these studies is discussed with the goal of presenting a complete synthesis of the current body of literature on AOM use in combination with bariatric surgery.</p>","PeriodicalId":10846,"journal":{"name":"Current Obesity Reports","volume":" ","pages":"377-402"},"PeriodicalIF":9.5,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140173993","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Weight Gain in Midlife Women. 中年女性体重增加

IF 9.5 2区医学

Current Obesity Reports Pub Date : 2024-06-01 Epub Date: 2024-02-28 DOI: 10.1007/s13679-024-00555-2

Maria D Hurtado, Mariam Saadedine, Ekta Kapoor, Chrisandra L Shufelt, Stephanie S Faubion

{"title":"Weight Gain in Midlife Women.","authors":"Maria D Hurtado, Mariam Saadedine, Ekta Kapoor, Chrisandra L Shufelt, Stephanie S Faubion","doi":"10.1007/s13679-024-00555-2","DOIUrl":"10.1007/s13679-024-00555-2","url":null,"abstract":"<p><strong>Purpose of review: </strong>To summarize the evidence and clinical implications of weight and body composition changes during midlife in women and provide an overview of weight gain prevention and management in this population.</p><p><strong>Recent findings: </strong>Aging-related changes such as decreased energy expenditure and physical activity are important culprits for weight gain in midlife women. The hormonal changes of menopause also influence body adiposity distribution and increase central adiposity. These body changes can have health consequences including the development of cardiometabolic diseases, osteoarthritis, cancer, worsening in cognition, mental health, and menopause symptoms. Midlife women experience changes related to aging, menopause, and lifestyle which favor weight gain. Clinical practice should focus on early counseling and anticipatory guidance on the importance of dietary changes and physical activity to attenuate this phenomenon. Future research should focus on the longitudinal relationship between weight trends in midlife and health consequences and mortality.</p>","PeriodicalId":10846,"journal":{"name":"Current Obesity Reports","volume":" ","pages":"352-363"},"PeriodicalIF":9.5,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11150086/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139982599","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

A Comprehensive Review of Syndromic Forms of Obesity: Genetic Etiology, Clinical Features and Molecular Diagnosis. 肥胖症综合征的全面回顾：遗传病因、临床特征和分子诊断。

IF 9.5 2区医学

Current Obesity Reports Pub Date : 2024-06-01 Epub Date: 2024-01-26 DOI: 10.1007/s13679-023-00543-y

Laura Machado Lara Carvalho, Alexander Augusto de Lima Jorge, Débora Romeo Bertola, Ana Cristina Victorino Krepischi, Carla Rosenberg

{"title":"A Comprehensive Review of Syndromic Forms of Obesity: Genetic Etiology, Clinical Features and Molecular Diagnosis.","authors":"Laura Machado Lara Carvalho, Alexander Augusto de Lima Jorge, Débora Romeo Bertola, Ana Cristina Victorino Krepischi, Carla Rosenberg","doi":"10.1007/s13679-023-00543-y","DOIUrl":"10.1007/s13679-023-00543-y","url":null,"abstract":"<p><p>Syndromic obesity refers to obesity occurring with additional clinical findings, such as intellectual disability/developmental delay, dysmorphic features, and congenital malformations. PURPOSE OF REVIEW: To present a narrative review regarding the genetic etiology, clinical description, and molecular diagnosis of syndromic obesity, which is a rare condition with high phenotypic variability and genetic heterogeneity. The following syndromes are presented in this review: Prader-Willi, Bardet-Biedl, Pseudohypoparathyroidism, Alström, Smith-Magenis, Cohen, Temple, 1p36 deletion, 16p11.2 microdeletion, Kleefstra, SIM1-related, Börjeson-Forssman-Lehmann, WAGRO, Carpenter, MORM, and MYT1L-related syndromes. RECENT FINDINGS: There are three main groups of mechanisms for syndromic obesity: imprinting, transcriptional activity regulation, and cellular cilia function. For molecular diagnostic, methods of genome-wide investigation should be prioritized over sequencing of panels of syndromic obesity genes. In addition, we present novel syndromic conditions that need further delineation, but evidences suggest they have a higher frequency of obesity. The etiology of syndromic obesity tends to be linked to disrupted neurodevelopment (central) and is associated with a diversity of genes and biological pathways. In the genetic investigation of individuals with syndromic obesity, the possibility that the etiology of the syndromic condition is independent of obesity should be considered. The accurate genetic diagnosis impacts medical management, treatment, and prognosis, and allows proper genetic counseling.</p>","PeriodicalId":10846,"journal":{"name":"Current Obesity Reports","volume":" ","pages":"313-337"},"PeriodicalIF":9.5,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139564043","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Role of Glucocorticoids in Metabolic Dysfunction-Associated Steatotic Liver Disease. 糖皮质激素在代谢功能障碍相关性脂肪肝中的作用

IF 9.5 2区医学

Current Obesity Reports Pub Date : 2024-06-01 Epub Date: 2024-03-08 DOI: 10.1007/s13679-024-00556-1

Stergios A Polyzos, Giovanni Targher

{"title":"Role of Glucocorticoids in Metabolic Dysfunction-Associated Steatotic Liver Disease.","authors":"Stergios A Polyzos, Giovanni Targher","doi":"10.1007/s13679-024-00556-1","DOIUrl":"10.1007/s13679-024-00556-1","url":null,"abstract":"<p><strong>Purpose of the review: </strong>To summarize published data on the association between glucocorticoids and metabolic dysfunction-associated steatotic liver disease (MASLD), focusing on the possible pathophysiological links and related treatment considerations.</p><p><strong>Recent findings: </strong>Glucocorticoids, commonly used for managing many inflammatory and autoimmune diseases, may contribute to the development and progression of MASLD. Glucocorticoids may induce hyperglycemia and hyperinsulinemia, thus increasing systemic and hepatic insulin resistance, a hallmark of MASLD pathogenesis. Furthermore, glucocorticoids increase adipose tissue lipolysis, and hepatic de novo lipogenesis and decrease hepatic fatty acid β-oxidation, thus promoting MASLD development. Preclinical evidence also suggests that glucocorticoids may adversely affect hepatic inflammation and fibrosis. 11beta-hydroxysteroid dehydrogenase type 1 (11β-HSD1) and 5α-reductase are implicated in the link between glucocorticoids and MASLD, the former enzyme increasing and the latter reducing the glucocorticoid action on the liver. Treatment considerations exist due to the pathogenic link between glucocorticoids and MASLD. Since iatrogenic hypercortisolism is common, glucocorticoids should be used at the minimum daily dose to control the subjective disease. Furthermore, the pharmacologic inhibition of 11β-HSD1 has provided favorable results in MASLD, both in preclinical studies and early MASH clinical trials. Glucocorticoids are closely linked to MASLD pathophysiology, with specific clinical and therapeutic implications.</p>","PeriodicalId":10846,"journal":{"name":"Current Obesity Reports","volume":" ","pages":"242-255"},"PeriodicalIF":9.5,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11150302/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140065039","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Potential Micronutrient Deficiencies in the First 1000 Days of Life: The Pediatrician on the Side of the Weakest. 生命最初 1000 天的潜在微量营养素缺乏症：站在最弱者一边的儿科医生。

IF 9.5 2区医学

Current Obesity Reports Pub Date : 2024-06-01 Epub Date: 2024-03-21 DOI: 10.1007/s13679-024-00554-3

Carolà Panzeri, Luca Pecoraro, Alice Dianin, Andrea Sboarina, Olivia C Arnone, Giorgio Piacentini, Angelo Pietrobelli

{"title":"Potential Micronutrient Deficiencies in the First 1000 Days of Life: The Pediatrician on the Side of the Weakest.","authors":"Carolà Panzeri, Luca Pecoraro, Alice Dianin, Andrea Sboarina, Olivia C Arnone, Giorgio Piacentini, Angelo Pietrobelli","doi":"10.1007/s13679-024-00554-3","DOIUrl":"10.1007/s13679-024-00554-3","url":null,"abstract":"<p><strong>Purpose of review: </strong>This study is to examine potential micronutrient deficiencies and any need for supplementation in children following specific diet plans in the first 1000 days of life.</p><p><strong>Recent findings: </strong>Optimal nutrition in the first 1000 days of life has a lifelong positive impact on child development. Specific intrauterine and perinatal factors, pathological conditions, and dietary restrictions can represent potential risk factors for micronutrient deficiencies in the first 1000 days of life, which can have negative systemic consequences. Preterm and low-birth-weight infants are intrinsically at risk because of immature body systems. Children affected by cystic fibrosis are prone to malnutrition because of intestinal malabsorption. The risk of micronutrient deficiency can increase in various situations, including but not limited to children following selective dietary regimens (vegetarian and vegan diets and children affected by specific neuropsychiatric conditions) or specific dietary therapies (children affected by food allergies or specific metabolic disorders and children following restricted diet as a part of therapeutic approach, i.e., ketogenic diet for epilepsy). In light of this situation, the micronutrient status in these categories of children should be investigated in order to tailor strategies specific to the individual's metabolic needs, with a particular focus on deficiencies which can impair or delay the physical and cognitive development of children, namely, vitamin B12, vitamin D and folic acid, as well as oligo-elements such as iron, zinc, calcium, sodium, magnesium, and phosphorus, and essential fatty acids such as omega-3. Identification of micronutrient deficiency in the first 1000 days of life and timely supplementation proves essential to prevent their long-term consequences.</p>","PeriodicalId":10846,"journal":{"name":"Current Obesity Reports","volume":" ","pages":"338-351"},"PeriodicalIF":9.5,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11150320/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140183969","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Update on Pediatric Anti-obesity Medications—Current Landscape and Approach to Prescribing 儿科抗肥胖药物的最新情况--当前形势和处方方法

IF 8.8 2区医学

Current Obesity Reports Pub Date : 2024-04-30 DOI: 10.1007/s13679-024-00566-z

Yoon Ji Ahn, Jacqueline Maya, Vibha Singhal

{"title":"Update on Pediatric Anti-obesity Medications—Current Landscape and Approach to Prescribing","authors":"Yoon Ji Ahn, Jacqueline Maya, Vibha Singhal","doi":"10.1007/s13679-024-00566-z","DOIUrl":"https://doi.org/10.1007/s13679-024-00566-z","url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Purpose of Review</h3><p>To review the current medical therapies available for treatment of obesity in children and adolescents less than 18 years old in the United States and outline the approach to their use.</p><h3 data-test=\"abstract-sub-heading\">Recent Findings</h3><p>Obesity is a chronic disease with increasing prevalence in children and adolescents in the United States. Over the past few years, more FDA-approved medical treatments for obesity, such as GLP-1 receptor agonists, have emerged for patients less than 18 years old. Furthermore, there are medications with weight loss effects that can be used off-label for obesity in pediatric patients. However, access to many of these medications is limited due to age restrictions, insurance coverage, and cost.</p><h3 data-test=\"abstract-sub-heading\">Summary</h3><p>Medical options are improving to provide treatment for obesity in pediatric populations. FDA and off-label medications should be considered when appropriate to treat children and adolescents with obesity. However, further studies are needed to evaluate the efficacy and long-term safety of FDA-approved and off-label medications for obesity treatment in pediatric patients.</p>","PeriodicalId":10846,"journal":{"name":"Current Obesity Reports","volume":"11 1","pages":""},"PeriodicalIF":8.8,"publicationDate":"2024-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140838701","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

The Different Shades of Thermogenic Adipose Tissue 不同颜色的致热脂肪组织

IF 8.8 2区医学

Current Obesity Reports Pub Date : 2024-04-12 DOI: 10.1007/s13679-024-00559-y

Yunwen Hu, Yijie Huang, Yangjing Jiang, Lvkan Weng, Zhaohua Cai, Ben He

{"title":"The Different Shades of Thermogenic Adipose Tissue","authors":"Yunwen Hu, Yijie Huang, Yangjing Jiang, Lvkan Weng, Zhaohua Cai, Ben He","doi":"10.1007/s13679-024-00559-y","DOIUrl":"https://doi.org/10.1007/s13679-024-00559-y","url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Purpose of Review</h3><p>By providing a concise overview of adipose tissue types, elucidating the regulation of adipose thermogenic capacity in both physiological contexts and chronic wasting diseases (a protracted hypermetabolic state that precipitates sustained catabolism and consequent progressive corporeal atrophy), and most importantly, delving into the ongoing discourse regarding the role of adipose tissue thermogenic activation in chronic wasting diseases, this review aims to provide researchers with a comprehensive understanding of the field.</p><h3 data-test=\"abstract-sub-heading\">Recent Findings</h3><p>Adipose tissue, traditionally classified as white, brown, and beige (brite) based on its thermogenic activity and potential, is intricately regulated by complex mechanisms in response to exercise or cold exposure. This regulation is adipose depot-specific and dependent on the duration of exposure. Excessive thermogenic activation of adipose tissue has been observed in chronic wasting diseases and has been considered a pathological factor that accelerates disease progression. However, this conclusion may be confounded by the detrimental effects of excessive lipolysis. Recent research also suggests that such activation may play a beneficial role in the early stages of chronic wasting disease and provide potential therapeutic effects.</p><h3 data-test=\"abstract-sub-heading\">Summary</h3><p>A more comprehensive understanding of the changes in adipose tissue thermogenesis under physiological and pathological conditions, as well as the underlying regulatory mechanisms, is essential for the development of novel interventions to improve health and prevent disease.</p>","PeriodicalId":10846,"journal":{"name":"Current Obesity Reports","volume":"30 1","pages":""},"PeriodicalIF":8.8,"publicationDate":"2024-04-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140597610","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Specific and Non-specific Aspects and Future Challenges of ICU Care Among COVID-19 Patients with Obesity: A Narrative Review COVID-19 肥胖症患者重症监护室护理的特殊和非特殊方面及未来挑战：叙述性综述

IF 8.8 2区医学

Current Obesity Reports Pub Date : 2024-04-04 DOI: 10.1007/s13679-024-00562-3

Alexandra Beurton, Emma J. Kooistra, Audrey De Jong, Helmut Schiffl, Mercedes Jourdain, Bruno Garcia, Damien Vimpère, Samir Jaber, Peter Pickkers, Laurent Papazian

{"title":"Specific and Non-specific Aspects and Future Challenges of ICU Care Among COVID-19 Patients with Obesity: A Narrative Review","authors":"Alexandra Beurton, Emma J. Kooistra, Audrey De Jong, Helmut Schiffl, Mercedes Jourdain, Bruno Garcia, Damien Vimpère, Samir Jaber, Peter Pickkers, Laurent Papazian","doi":"10.1007/s13679-024-00562-3","DOIUrl":"https://doi.org/10.1007/s13679-024-00562-3","url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Purpose of Review</h3><p>Since the end of 2019, the coronavirus disease 2019 (COVID-19) pandemic has infected nearly 800 million people and caused almost seven million deaths. Obesity was quickly identified as a risk factor for severe COVID-19, ICU admission, acute respiratory distress syndrome, organ support including mechanical ventilation and prolonged length of stay. The relationship among obesity; COVID-19; and respiratory, thrombotic, and renal complications upon admission to the ICU is unclear.</p><h3 data-test=\"abstract-sub-heading\">Recent Findings</h3><p>The predominant effect of a hyperinflammatory status or a cytokine storm has been suggested in patients with obesity, but more recent studies have challenged this hypothesis. Numerous studies have also shown increased mortality among critically ill patients with obesity and COVID-19, casting doubt on the obesity paradox, with survival advantages with overweight and mild obesity being reported in other ICU syndromes. Finally, it is now clear that the increase in the global prevalence of overweight and obesity is a major public health issue that must be accompanied by a transformation of our ICUs, both in terms of equipment and human resources. Research must also focus more on these patients to improve their care.</p><h3 data-test=\"abstract-sub-heading\">Summary</h3><p>In this review, we focused on the central role of obesity in critically ill patients during this pandemic, highlighting its specificities during their stay in the ICU, identifying the lessons we have learned, and identifying areas for future research as well as the future challenges for ICU activity.</p>","PeriodicalId":10846,"journal":{"name":"Current Obesity Reports","volume":"69 1","pages":""},"PeriodicalIF":8.8,"publicationDate":"2024-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140596943","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Expert Opinion on the Utility of Telemedicine in Obesity Care: Recommendations on a Hybrid Multidisciplinary Integrated Care Follow-Up Algorithm. 关于远程医疗在肥胖症护理中的实用性的专家意见：关于混合式多学科综合护理随访算法的建议。

IF 9.5 2区医学

Current Obesity Reports Pub Date : 2024-03-01 Epub Date: 2024-01-03 DOI: 10.1007/s13679-023-00541-0

Fahri Bayram, Alper Sonmez, Sinem Kiyici, Feray Akbas, Meral Kucuk Yetgin, Dilek Yazici, Asim Cingi, Mehmet Sargin, Seniz Unal, Ceren Iseri, Fatih Selami Mahmutoglu, Volkan Demirhan Yumuk

{"title":"Expert Opinion on the Utility of Telemedicine in Obesity Care: Recommendations on a Hybrid Multidisciplinary Integrated Care Follow-Up Algorithm.","authors":"Fahri Bayram, Alper Sonmez, Sinem Kiyici, Feray Akbas, Meral Kucuk Yetgin, Dilek Yazici, Asim Cingi, Mehmet Sargin, Seniz Unal, Ceren Iseri, Fatih Selami Mahmutoglu, Volkan Demirhan Yumuk","doi":"10.1007/s13679-023-00541-0","DOIUrl":"10.1007/s13679-023-00541-0","url":null,"abstract":"<p><strong>Purpose of review: </strong>The proposed expert opinion was prepared by a panel of obesity and law specialists from Turkey to review the utility of telemedicine in obesity care and to provide a guidance document with recommendations on a hybrid multidisciplinary integrated care follow-up algorithm and the legislation governing telemedicine practice to assist obesity specialists in practicing the telemedicine.</p><p><strong>Recent findings: </strong>The efficacy and feasibility of telemedicine interventions in supporting obesity management programs even during pandemics confirm that obesity is a particularly well-suited field for telemedicine, emphasizing the strong likelihood of continued utilization of telemedicine in obesity management, beyond the pandemic period. Telemedicine has great potential to address several barriers to ongoing weight-management care, such as challenges of access to specialized care, cost, and time limitations as well as patient adherence to treatment. However, telemedicine practice should complement rather than replace the in-person visits which are unique in building rapport and offering social support. Accordingly, the participating experts recommend the use of a hybrid integrated care model in the management of obesity, with the use of telemedicine, as an adjunct to in-person visits, to enable the provision of suggested intensive obesity management via frequent visits by a multidisciplinary team of obesity specialists. Further research addressing the utility of telemedicine in terms of optimal modality and duration for successful long-term obesity management outcomes is necessary to develop specific guidelines on telemedicine practice. In addition, the legislation governing the norms and protocols on confidentiality, privacy, access, and liability needs to be improved.</p>","PeriodicalId":10846,"journal":{"name":"Current Obesity Reports","volume":" ","pages":"167-182"},"PeriodicalIF":9.5,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139086250","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0